PRINCETON, N.J., April 3, 2013 /PRNewswire/ -- The WIRB-Copernicus Group, the world's largest provider of regulatory and ethical review services for human research, announced today that Jeffrey A. Cooper, MD, MMM, Vice President of Global Consulting for The WIRB-Copernicus Group and Carrie Fisher, PhD, MBA, Vice President of Process Development and Training for Western Institutional Review Board (WIRB) have been invited to speak at the upcoming International Conference of The Association for the Accreditation of Human Research Protection Programs (AAHRPP) in Miami, Florida on April 3-5, 2013.
"The WIRB-Copernicus Group is pleased that Dr. Cooper and Dr. Fisher have been invited to speak at the AAHRPP Conference, and we are proud to support AAHRPP in its mission to promote high-quality research and strengthen human research protection programs through accreditation," said Stuart Horowitz, PhD, MBA, President of Institutions and Institutional Services for The WIRB-Copernicus Group. "The WIRB-Copernicus Group brings more expertise to the industry than any other ethical solutions provider, and through its Consulting and Technology Divisions, is uniquely poised to support institutional clients in achieving the goal of AAHRPP accreditation."
Dr. Cooper is one of the founders of AAHRPP and was responsible for the development and operation of its accreditation process from 2002 to 2009. In his capacity within the Consulting Division of The WIRB-Copernicus Group, Dr. Cooper works with a team of former AAHRPP accreditors and site visitors, as well as current AAHRPP council members, to provide expert guidance to institutions considering AAHRPP accreditation, or undergoing the accreditation or reaccreditation process.At the upcoming AAHRPP conference, Dr. Cooper will moderate a luncheon session entitled, "The Flexible IRB," during which he will lead the Flexibility Coalition in an informal discussion regarding overlooked opportunities for flexibility within the ethical review process. The majority of Dr. Cooper's recommendations can be accomplished without going outside of regulatory requirements, and with HHS-funded research, which represents an innovative step forward for the industry.